scholarly journals VP19.12: Rescue indomethacin: a supportive treatment to cerclage for cervical insufficiency at a previable gestation

2021 ◽  
Vol 58 (S1) ◽  
pp. 178-179
Author(s):  
R.M. Moses ◽  
M. Martin ◽  
I. Alahakoon
Keyword(s):  
Cervical Insufficiency ◽  
Supportive Treatment

Sophistry and Circumstance at the End of Life

2008 ◽  
Vol 5 (1) ◽  
pp. 81-88
Author(s):  
Philip Berry
Keyword(s):  
Liver Failure ◽  
Medical Personnel ◽  
Medical Decision ◽  
Loss Of Consciousness ◽  
Supportive Treatment ◽  
Medical Decisions ◽  
Life Threatening Illness ◽  
Two Factors ◽  
Life Threatening ◽  
Counselling Process

When life-threatening illness robs a patient of the ability to express their desires, medical personnel must work through the issues of management and prognosis with relatives. Management decisions are guided by medical judgement and the relatives’ account of the patient’s wishes, but difficulties occur when distance grows between these two factors. In these circumstances the counselling process may turn into a doctor-led justification of the medical decision. This article presents two strands of dialogue, in which a doctor, counselling for and against continuation of supportive treatment in two patients with liver failure, demonstrates selectivity and inconsistency in constructing an argument. The specific issues of loss of consciousness (with obscuration of personal identity), statistical ‘futility’ and removal of autonomy are explored and used to bolster diametrically opposed medical decisions. By examining the doctor’s ability to interpret these issues according to circumstance, the author demonstrates how it is possible to shade medical facts depending on the desired outcome.

PRETERM LABOR WITH CERVICAL INSUFFICIENCY

2018 ◽  
Vol 20 (4) ◽  
pp. 115-119
Author(s):  
Yu.A. Petrov ◽  
◽  
A.G. Alekhina ◽  
A.E. Blesmanovich ◽  
◽  
...  
Keyword(s):  
Preterm Labor ◽  
Cervical Insufficiency

scholarly journals Resolution of acute cervical insufficiency after antibiotics in a case with amniotic fluid sludge

2021 ◽  
pp. 1-11
Author(s):  
Lami Yeo ◽  
Roberto Romero ◽  
Tinnakorn Chaiworapongsa ◽  
Robert Para ◽  
Jeffrey Johnson ◽  
...  
Keyword(s):  
Amniotic Fluid ◽  
Cervical Insufficiency

Empathy-based supportive treatment in amyotrophic lateral sclerosis: A pragmatic study

2021 ◽  
Vol 63 (3) ◽  
pp. 202-216
Author(s):  
Arianna Palmieri ◽  
Johann R. Kleinbub ◽  
Francesco Pagnini ◽  
Gianni Sorarù ◽  
Sabrina Cipolletta
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Supportive Treatment ◽  
Lateral Sclerosis ◽  
Pragmatic Study

ACE inhibitor induced visceral angioedema: an elusive diagnosis

2020 ◽  
Vol 13 (11) ◽  
pp. e236391 ◽  
Author(s):  
Metlapalli Venkata Sravanthi ◽  
Sharmil Suma Kumaran ◽  
Nishant Sharma ◽  
Bojana Milekic
Keyword(s):  
Adverse Effect ◽  
African American ◽  
Abdominal Pain ◽  
Ace Inhibitors ◽  
Ace Inhibitor ◽  
Lower Abdominal Pain ◽  
Supportive Treatment ◽  
Newly Diagnosed ◽  
Radiographic Findings ◽  
Missed Diagnosis

ACE inhibitors are widely used and well-tolerated drugs. Angioedema is a well-known adverse effect, which involves the viscera rarely. This is a case of a 44-year-old African-American man with newly diagnosed hypertension, who presented with lower abdominal pain and diarrhoea. Based on the clinical picture and radiographic findings, lisinopril-induced intestinal angioedema was diagnosed. He recovered with supportive treatment, and the lisinopril was permanently discontinued. The mechanism of angioedema is thought to be the inhibition of ACE-mediated degradation of bradykinin, which is a peptide responsible for vasodilation and increased vascular permeability. While the external angioedema is unmistakable, intestinal angioedema has a relatively non-specific presentation and chronology, often leading to missed diagnosis and unnecessary interventions. Most common symptoms are abdominal pain and diarrhoea. Characteristic radiographic findings include ‘doughnut sign’ and ‘stacked coin’ appearance. Treatment is supportive. ACE inhibitors should be discontinued to prevent a recurrence.

Cervical insufficiency: a noteworthy disease with controversies

2020 ◽  
Vol 48 (7) ◽  
pp. 648-655
Author(s):  
Yu Han ◽  
Mengnan Li ◽  
Huijing Ma ◽  
Hailan Yang
Keyword(s):  
Risk Factors ◽  
Diagnosis And Treatment ◽  
Practical Significance ◽  
Future Research ◽  
Cervical Insufficiency ◽  
Factors Associated ◽  
The World ◽  
Potential Risk Factors ◽  
Recurrent Pregnancy Losses ◽  
Recurrent Abortions

AbstractCervical insufficiency (CI) is a mainly disease leading to recurrent abortions and preterm birth which may present in about 1% of obstetric populations. Recurrent pregnancy losses caused by CI incur serious economic burdens on society as well as huge psychological burdens to family members. However, many patients even clinicians in some areas of the world still remain confused about this disease. At the same time, the etiology of CI is still uncertain and it is still a controversial disease in diagnosis and treatment. This article summarizes the potential risk factors associated with CI, which could be worthy of attention and helpful for future research. It also reviews the methods for diagnosis and treatment of CI to better understand this noteworthy disease, as well as presents the related consensus and controversies according to the newly updated guidelines, which has practical significance for conducting more in-depth investigations in the future.

Yellow Fever

2021 ◽  
Author(s):  
Melvin Sanicas ◽  
Merlin Sanicas
Keyword(s):  
South America ◽  
Yellow Fever ◽  
Survival Rates ◽  
Antiviral Drug ◽  
Specific Treatment ◽  
Preventive Measure ◽  
Hemorrhagic Disease ◽  
Supportive Treatment ◽  
Tropical Areas ◽  
At Risk Populations

Yellow fever is an acute viral hemorrhagic disease transmitted by infected mosquitoes. The "yellow" in the name refers to the jaundice from direct liver damage. The virus is endemic in tropical areas of Africa and Central and South America. There is no specific treatment or antiviral drug for yellow fever but appropriate supportive treatment in hospitals improves survival rates. Vaccination is the single most important preventive measure. Several yellow fever vaccines are manufactured by different developers. All of them are safe, affordable, and appear to provide protection for >30–35 years. Some are WHO-prequalified. The Eliminate Yellow Fever Epidemics (EYE) Strategy launched in 2017 aims at protecting at-risk populations, preventing international spread, and containing outbreaks rapidly. By 2026, it is expected that more than 1 billion people will be protected against the disease.

Sign in / Sign up

Export Citation Format

Share Document